Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 No DAC / Ipamorelin Blend 5/5mg | Palmetto Peptides

CJC-1295 No DAC / Ipamorelin Blend 5/5mg 10/10mg GH Secretagogue Research Stack · COA Verified For research and laboratory use only. Not for human consumption. By purchasing, you confirm you are a qualified researcher. Product Details For Research Purposes Only. Not approved for human consumption. CJC-1295 No DAC / Ipamorelin Research Blend The CJC-1295 No DAC / Ipamorelin Blend combines two complementary growth hormone secretagogues into a single, precisely formulated research compound. CJC-1295 No DAC (Mod GRF 1-29) acts on the GHRH receptor to amplify pulsatile GH release; Ipamorelin selectively targets the ghrelin receptor (GHS-R1a) to stimulate GH secretion with minimal cortisol or prolactin impact. Together they engage dual GH-release pathways, making this combination one of the most-studied GH secretagogue stacks in preclinical research. Research Applications Pulsatile growth hormone secretion research Dual-receptor GH stimulation studies (GHRH + ghrelin pathway) Body compositio

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

CJC-1295 No DAC / Ipamorelin Blend 5/5mg 10/10mg

GH Secretagogue Research Stack · COA Verified

For research and laboratory use only. Not for human consumption. By purchasing, you confirm you are a qualified researcher.

Product Details

For Research Purposes Only. Not approved for human consumption.

CJC-1295 No DAC / Ipamorelin Research Blend

The CJC-1295 No DAC / Ipamorelin Blend combines two complementary growth hormone secretagogues into a single, precisely formulated research compound. CJC-1295 No DAC (Mod GRF 1-29) acts on the GHRH receptor to amplify pulsatile GH release; Ipamorelin selectively targets the ghrelin receptor (GHS-R1a) to stimulate GH secretion with minimal cortisol or prolactin impact. Together they engage dual GH-release pathways, making this combination one of the most-studied GH secretagogue stacks in preclinical research.

Research Applications

Pulsatile growth hormone secretion research

Dual-receptor GH stimulation studies (GHRH + ghrelin pathway)

Body composition and metabolic research models

Sleep quality and recovery research

Anti-aging and longevity peptide research

Quality Specifications

Purity: ≥98% (HPLC verified)

Compounds: CJC-1295 No DAC (Mod GRF 1-29) + Ipamorelin

Molecular Weight: 3367.9 Da (CJC) / 711.9 Da (Ipamorelin)

Form: Lyophilized powder (co-lyophilized blend)

Origin: Made in the USA

Testing: Third-party tested in a US laboratory

Storage: -20°C, protect from light

COA: Batch-specific, ISO-accredited laboratory

Frequently Asked Questions

Q: Why combine CJC-1295 No DAC and Ipamorelin?A: They work through different receptor pathways — CJC-1295 No DAC activates GHRH receptors; Ipamorelin activates GHS-R1a (ghrelin receptors). Research shows these pathways are synergistic, producing greater GH pulse amplitude than either compound alone.

Q: What is CJC-1295 No DAC?A: Also called Mod GRF 1-29, this is a truncated, stabilized GHRH analog without the Drug Affinity Complex (DAC) modification. It produces short, pulsatile GH release that mimics natural GH secretion patterns.

Q: What is Ipamorelin?A: A selective growth hormone releasing peptide (GHRP) that stimulates GH secretion with high selectivity and minimal effect on cortisol or prolactin.

Q: Are both peptides in the same vial?A: Yes. This is a co-lyophilized blend with both compounds at equal proportions per the selected dose variant.

Related Research: CJC-1295 No DAC Standalone | Ipamorelin Standalone

For laboratory research use only. Not for human consumption. Not evaluated by the FDA.

Connected topics

Follow this recovery question